Enovis to Debut Pecaplasty ‘Wires First’ Bunion Surgery Tech

Enovis will debut its new Pecaplasty Wires First system at this year’s American Orthopaedic Foot & Ankle Society (AOFAS) annual meeting.

The company has advanced the Pecaplasty system since adding it to its foot and ankle portfolio after the 2023 acquisition of Novastep. The technology is used in percutaneous bunion surgery.

“The wires first approach provides a simple and predictable modality for minimally invasive bunion correction that will change the game for surgeons,” said Dr. Amiethab Aiyer, MD, a foot and ankle surgeon at Johns Hopkins University/School of Medicine, Department of Orthopaedics. “With wires first, both you and your patients win.”

Enovis will also host a surgeon-led event at AOFAS called Wires 500 that offers hands-on Pecaplasty Wires First demos.

“Pecaplasty Wires First is a leap forward in MIS bunion surgery—helping surgeons achieve reproducible outcomes through an intuitive technique,” said Gary Justak, president and general manager of Enovis Foot & Ankle. “Building on the legacy of Novastep, this second-generation platform puts Enovis out in front of every first-gen product on the market. We tackled the most challenging step of the case to shorten the learning curve so surgeons adopt faster and patients benefit sooner through improved outcomes.”

Last month, the company launched the Manafuse bone growth stimulator, a portable, battery-powered medical device indicated for daily use to noninvasively treat indicated fresh fractures and fracture nonunion.